Squeezing cells to cure diseases
Startup SQZ Biotech aims to open a new path in immunotherapy with its cell-compressing technique.
Startup SQZ Biotech aims to open a new path in immunotherapy with its cell-compressing technique.
Delivered together, the two join forces to eradicate drug-resistant bacteria.
Four other MIT researchers to receive New Horizons Prizes in math and physics; two alumni win Breakthrough Prize in Fundamental Physics.
Deep-learning model has been used successfully on patients, may lead to more consistent screening procedures.
New approach generates a wider variety of protein sequences optimized to bind to drug targets.
New MIT initiative delves into the biology of stem cells and cancer stem cells, seeks ways to identify, purify, and propagate them.
Lustgarten Foundation names MIT laboratory to improve understanding and treatment of a deadly disease
Natural killer cells’ failure to respond to infection may explain why the disease is more grave in some patients.
System can be rapidly reconfigured to produce a variety of protein drugs.
Three MIT postdocs earn competitive Howard Hughes Medical Institute fellowships that support diversity in the sciences.
Tiny probes could be useful for monitoring patients with Parkinson’s and other diseases.
Matthew Vander Heiden seeks new cancer treatments that exploit tumor cells’ abnormal metabolism.
Biologists discover that the environment surrounding a cell plays an integral role in its ability to accurately segregate its chromosomes.
Findings suggest mechanisms for the persistence of nasal polyps and possible new treatment strategies.
The new Convergence Scholars Program bridges disciplines and helps young researchers further their skills and build their brands as scientists.